A

Applied Therapeutics
D

APLT

9.62000
USD
0.36
(3.89%)
Market Closed
Volume
75,757
EPS
-1
Div Yield
-
P/E
-7
Market Cap
1,119,349,280
OverviewSignalsIdeasNews
Related Instruments
    A
    APDN
    -0.01260
    (-7.25%)
    0.16110 USD
    A
    APT
    0.07000
    (1.34%)
    5.30000 USD
    A
    APTO
    -0.01930
    (-5.01%)
    0.36570 USD
    A
    APTV
    -1.110
    (-2.05%)
    52.930 USD
    A
    APTX
    0
    (0%)
    0.000000 USD
    More
News

Title: Applied Therapeutics

Sector: Healthcare
Industry: Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.